BRD4 inhibitors block telomere elongation (Q56507869)

No description defined

Language	Label	Description	Also known as
English	BRD4 inhibitors block telomere elongation	No description defined

Statements

instance of

scholarly article

0 references

title

BRD4 inhibitors block telomere elongation (English)

0 references

Carla Connelly

4

0 references

Carol Greider

series ordinal

5

object named as

Carol W. Greider

0 references

author name string

Steven Wang

series ordinal

1

0 references

Alexandra Pike

series ordinal

2

0 references

Stella Lee

series ordinal

3

0 references

publication date

27 February 2017

0 references

published in

bioRxiv

0 references

cites work

Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Targeting cancer with small molecule kinase inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

The short and long telomere syndromes: paired paradigms for molecular medicine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomerase mutations in families with idiopathic pulmonary fibrosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomeres shorten during ageing of human fibroblasts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomerase and cancer therapeutics

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Regulation of telomerase by telomeric proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Bromodomain 4: a cellular Swiss army knife

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Tankyrase, a poly(ADP-ribose) polymerase at human telomeres

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

MEC3, MEC1, and DDC2 are essential components of a telomere checkpoint pathway required for cell cycle arrest during senescence in Saccharomyces cerevisiae

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomerase activation. One step on the road to cancer?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

DNA degradation at unprotected telomeres in yeast is regulated by the CDK1 (Cdc28/Clb) cell-cycle kinase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Targeting MYC dependence in cancer by inhibiting BET bromodomains

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

DNA-damage response and repair activities at uncapped telomeres depend on RNF8

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

ATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

The POT1-TPP1 telomere complex is a telomerase processivity factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

BRD4 is a novel therapeutic target for liver fibrosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

TERT promoter mutations in familial and sporadic melanoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Regulation of telomere elongation by the cyclin-dependent kinase CDK1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

The telomere syndromes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

High-throughput RNAi screening reveals novel regulators of telomerase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomerase, cell immortality, and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomeres, telomerase and senescence

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Imetelstat (GRN163L)--telomerase-based cancer therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Suppression of inflammation by a synthetic histone mimic

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomeres and age-related disease: how telomere biology informs clinical paradigms

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

How shelterin protects mammalian telomeres

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Selective inhibition of BET bromodomains

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Flow cytometry and FISH to measure the average length of telomeres (flow FISH).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Identification of a specific telomere terminal transferase activity in Tetrahymena extracts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

A highly selective telomerase inhibitor limiting human cancer cell proliferation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Fast gapped-read alignment with Bowtie 2

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomerase activity in human breast tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Telomere length homeostasis requires that telomerase levels are limiting

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Highly recurrent TERT promoter mutations in human melanoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Control of human telomere length by TRF1 and TRF2

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Short telomeres induce a DNA damage response in Saccharomyces cerevisiae

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Treating Myeloproliferation--On Target or Off?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

RNAi screen for telomerase reverse transcriptase transcriptional regulators identifies HIF1alpha as critical for telomerase function in murine embryonic stem cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Understanding TERT Promoter Mutations: A Common Path to Immortality.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

A DNA damage checkpoint response in telomere-initiated senescence

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

A yeast chemical genetic screen identifies inhibitors of human telomerase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

An Overview on Small Molecule Inhibitors of BRD4.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1101/112169

Identifiers

DOI

10.1101/112169

0 references

BRD4 inhibitors block telomere elongation (Q56507869)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

BRD4 inhibitors block telomere elongation (Q56507869)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search